134 related articles for article (PubMed ID: 27211090)
1. [5. Inspection of Hepatocellular Carcinoma 3-Contrast for the Diagnosis of Hepatocellular Carcinoma: Techniques of Image Contrast and the Choice of MR Contrast Agent].
Kitoh Y
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 May; 72(5):441-51. PubMed ID: 27211090
[No Abstract] [Full Text] [Related]
2. [Dynamic MRI].
Araki T; Ichikawa T; Nakajima H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():292-5. PubMed ID: 11761959
[No Abstract] [Full Text] [Related]
3. [MR imaging of hepatocellular carcinoma using hepatocyte-specific contrast agent Gd-EOB-DTPA].
Tanaka O; Nishimura T; Yamagami T; Ichijo Y; Ouchi H; Ohno K; Mitsumoto Y; Mori T; Yoshikawa T
Nihon Shokakibyo Gakkai Zasshi; 2010 May; 107(5):703-11. PubMed ID: 20460843
[No Abstract] [Full Text] [Related]
4. Will CT take second billing to MR imaging for the diagnosis of hypervascular hepatocellular carcinomas hereafter?
Kanematsu M
Radiology; 2011 Aug; 260(2):607; author reply 607-8. PubMed ID: 21778455
[No Abstract] [Full Text] [Related]
5. Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.
Pastor CM
Radiology; 2010 Nov; 257(2):589. PubMed ID: 20959554
[No Abstract] [Full Text] [Related]
6. Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.
Granito A; Galassi M; Piscaglia F; Romanini L; Lucidi V; Renzulli M; Borghi A; Grazioli L; Golfieri R; Bolondi L
Aliment Pharmacol Ther; 2013 Feb; 37(3):355-63. PubMed ID: 23199022
[TBL] [Abstract][Full Text] [Related]
7. Optimal scanning protocol of arterial dominant phase for hypervascular hepatocellular carcinoma with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced MR.
Kagawa Y; Okada M; Kumano S; Katsube T; Imaoka I; Tanigawa N; Ishii K; Kudo M; Murakami T
J Magn Reson Imaging; 2011 Apr; 33(4):864-72. PubMed ID: 21448951
[TBL] [Abstract][Full Text] [Related]
8. Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.
Lee S; Kim SH; Park CK; Kim YS; Lee WJ; Lim HK
J Magn Reson Imaging; 2010 Sep; 32(3):719-25. PubMed ID: 20815073
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging.
Ito K
Eur J Radiol; 2006 May; 58(2):186-99. PubMed ID: 16413154
[TBL] [Abstract][Full Text] [Related]
10. MR imaging in cirrhosis and hepatocellular carcinoma.
Barr DC; Hussain HK
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):315-35. PubMed ID: 25086932
[TBL] [Abstract][Full Text] [Related]
11. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.
Motosugi U; Bannas P; Sano K; Reeder SB
J Magn Reson Imaging; 2015 Feb; 41(2):251-65. PubMed ID: 25104398
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of breath-hold multislice dynamic MRI of hepatocellular carcinomas].
Itoh K; Honjo K; Honma Y; Hatanaka M; Choji T; Uchisako H; Kuramitsu T; Tanaka N; Nakaki H; Matsumoto T
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Mar; 52(3):399-401. PubMed ID: 1315953
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic strategy in liver and pancreatic tumors: imaging diagnosis using MRT].
Langkowski JH
Rontgenblatter; 1989 Sep; 42(9):400-5. PubMed ID: 2552566
[TBL] [Abstract][Full Text] [Related]
15. Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma.
Suto Y; Shimatani Y
Br J Radiol; 1995 Feb; 68(806):116-20. PubMed ID: 7735739
[TBL] [Abstract][Full Text] [Related]
16. Education and imaging. Hepatobiliary and Pancreatic: Detection of early hepatocellular carcinoma by enhanced magnetic resonance imaging.
Eso Y; Marusawa H; Osaki Y
J Gastroenterol Hepatol; 2012 Feb; 27(2):416. PubMed ID: 22260287
[No Abstract] [Full Text] [Related]
17. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
18. MRI in the evaluation of hepatocellular nodules: role of pulse sequences and contrast agents.
Ichikawa T
Intervirology; 2004; 47(3-5):252-70. PubMed ID: 15383734
[TBL] [Abstract][Full Text] [Related]
19. [MR imaging during arteriography (MR arteriography) in the detection of hepatocellular carcinoma].
Fujita T; Choji T; Ito K; Hatanaka M; Suga K; Yoneshiro S; Matsumoto T; Nakada T; Nakanishi T
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Jun; 53(6):716-8. PubMed ID: 8393187
[TBL] [Abstract][Full Text] [Related]
20. Focal liver lesion detection and characterization with GD-EOB-DTPA.
Purysko AS; Remer EM; Veniero JC
Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
